Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Data integration, evolutionary modelling and pattern recognition using predictive AI models, can enable trial sponsors to aggregate, curate, and analyze large volumes of data, thereby, harnessing information captured during past trials to drive future therapy development initiatives,such as concerns related to clinical trial design, patient recruitment and retention, site selection, medical data interpretation and evaluation of treatment efficacy, which are encountered during trial conduct.
The global AI-based Clinical Trial Solution market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for AI-based Clinical Trial Solution is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for AI-based Clinical Trial Solution is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for AI-based Clinical Trial Solution in Drug Discovery is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of AI-based Clinical Trial Solution include AiCure, Antidote, Deep Lens, Saama Technologies, Trials.ai, Deep 6 AI, Innoplexus, Median Technologies and Mendel.ai, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for AI-based Clinical Trial Solution, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI-based Clinical Trial Solution.
Report Scope
The AI-based Clinical Trial Solution market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global AI-based Clinical Trial Solution market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the AI-based Clinical Trial Solution companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Segment by Type
Segment by Application
By Region
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of AI-based Clinical Trial Solution companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI-based Clinical Trial Solution Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Artificial Narrow Intelligence
1.2.3 Artificial General Intelligence
1.2.4 Artificial Super Intelligence
1.3 Market by Application
1.3.1 Global AI-based Clinical Trial Solution Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Drug Discovery
1.3.3 Drug Manufacturing
1.3.4 Drug Marketing
1.3.5 Diagnosis and Treatment
1.3.6 Clinical Trials
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global AI-based Clinical Trial Solution Market Perspective (2019-2030)
2.2 AI-based Clinical Trial Solution Growth Trends by Region
2.2.1 Global AI-based Clinical Trial Solution Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 AI-based Clinical Trial Solution Historic Market Size by Region (2019-2024)
2.2.3 AI-based Clinical Trial Solution Forecasted Market Size by Region (2025-2030)
2.3 AI-based Clinical Trial Solution Market Dynamics
2.3.1 AI-based Clinical Trial Solution Industry Trends
2.3.2 AI-based Clinical Trial Solution Market Drivers
2.3.3 AI-based Clinical Trial Solution Market Challenges
2.3.4 AI-based Clinical Trial Solution Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AI-based Clinical Trial Solution Players by Revenue
3.1.1 Global Top AI-based Clinical Trial Solution Players by Revenue (2019-2024)
3.1.2 Global AI-based Clinical Trial Solution Revenue Market Share by Players (2019-2024)
3.2 Global AI-based Clinical Trial Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by AI-based Clinical Trial Solution Revenue
3.4 Global AI-based Clinical Trial Solution Market Concentration Ratio
3.4.1 Global AI-based Clinical Trial Solution Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI-based Clinical Trial Solution Revenue in 2023
3.5 AI-based Clinical Trial Solution Key Players Head office and Area Served
3.6 Key Players AI-based Clinical Trial Solution Product Solution and Service
3.7 Date of Enter into AI-based Clinical Trial Solution Market
3.8 Mergers & Acquisitions, Expansion Plans
4 AI-based Clinical Trial Solution Breakdown Data by Type
4.1 Global AI-based Clinical Trial Solution Historic Market Size by Type (2019-2024)
4.2 Global AI-based Clinical Trial Solution Forecasted Market Size by Type (2025-2030)
5 AI-based Clinical Trial Solution Breakdown Data by Application
5.1 Global AI-based Clinical Trial Solution Historic Market Size by Application (2019-2024)
5.2 Global AI-based Clinical Trial Solution Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America AI-based Clinical Trial Solution Market Size (2019-2030)
6.2 North America AI-based Clinical Trial Solution Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America AI-based Clinical Trial Solution Market Size by Country (2019-2024)
6.4 North America AI-based Clinical Trial Solution Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AI-based Clinical Trial Solution Market Size (2019-2030)
7.2 Europe AI-based Clinical Trial Solution Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe AI-based Clinical Trial Solution Market Size by Country (2019-2024)
7.4 Europe AI-based Clinical Trial Solution Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific AI-based Clinical Trial Solution Market Size (2019-2030)
8.2 Asia-Pacific AI-based Clinical Trial Solution Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific AI-based Clinical Trial Solution Market Size by Region (2019-2024)
8.4 Asia-Pacific AI-based Clinical Trial Solution Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America AI-based Clinical Trial Solution Market Size (2019-2030)
9.2 Latin America AI-based Clinical Trial Solution Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America AI-based Clinical Trial Solution Market Size by Country (2019-2024)
9.4 Latin America AI-based Clinical Trial Solution Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AI-based Clinical Trial Solution Market Size (2019-2030)
10.2 Middle East & Africa AI-based Clinical Trial Solution Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa AI-based Clinical Trial Solution Market Size by Country (2019-2024)
10.4 Middle East & Africa AI-based Clinical Trial Solution Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AiCure
11.1.1 AiCure Company Detail
11.1.2 AiCure Business Overview
11.1.3 AiCure AI-based Clinical Trial Solution Introduction
11.1.4 AiCure Revenue in AI-based Clinical Trial Solution Business (2019-2024)
11.1.5 AiCure Recent Development
11.2 Antidote
11.2.1 Antidote Company Detail
11.2.2 Antidote Business Overview
11.2.3 Antidote AI-based Clinical Trial Solution Introduction
11.2.4 Antidote Revenue in AI-based Clinical Trial Solution Business (2019-2024)
11.2.5 Antidote Recent Development
11.3 Deep Lens
11.3.1 Deep Lens Company Detail
11.3.2 Deep Lens Business Overview
11.3.3 Deep Lens AI-based Clinical Trial Solution Introduction
11.3.4 Deep Lens Revenue in AI-based Clinical Trial Solution Business (2019-2024)
11.3.5 Deep Lens Recent Development
11.4 Saama Technologies
11.4.1 Saama Technologies Company Detail
11.4.2 Saama Technologies Business Overview
11.4.3 Saama Technologies AI-based Clinical Trial Solution Introduction
11.4.4 Saama Technologies Revenue in AI-based Clinical Trial Solution Business (2019-2024)
11.4.5 Saama Technologies Recent Development
11.5 Trials.ai
11.5.1 Trials.ai Company Detail
11.5.2 Trials.ai Business Overview
11.5.3 Trials.ai AI-based Clinical Trial Solution Introduction
11.5.4 Trials.ai Revenue in AI-based Clinical Trial Solution Business (2019-2024)
11.5.5 Trials.ai Recent Development
11.6 Deep 6 AI
11.6.1 Deep 6 AI Company Detail
11.6.2 Deep 6 AI Business Overview
11.6.3 Deep 6 AI AI-based Clinical Trial Solution Introduction
11.6.4 Deep 6 AI Revenue in AI-based Clinical Trial Solution Business (2019-2024)
11.6.5 Deep 6 AI Recent Development
11.7 Innoplexus
11.7.1 Innoplexus Company Detail
11.7.2 Innoplexus Business Overview
11.7.3 Innoplexus AI-based Clinical Trial Solution Introduction
11.7.4 Innoplexus Revenue in AI-based Clinical Trial Solution Business (2019-2024)
11.7.5 Innoplexus Recent Development
11.8 Median Technologies
11.8.1 Median Technologies Company Detail
11.8.2 Median Technologies Business Overview
11.8.3 Median Technologies AI-based Clinical Trial Solution Introduction
11.8.4 Median Technologies Revenue in AI-based Clinical Trial Solution Business (2019-2024)
11.8.5 Median Technologies Recent Development
11.9 Mendel.ai
11.9.1 Mendel.ai Company Detail
11.9.2 Mendel.ai Business Overview
11.9.3 Mendel.ai AI-based Clinical Trial Solution Introduction
11.9.4 Mendel.ai Revenue in AI-based Clinical Trial Solution Business (2019-2024)
11.9.5 Mendel.ai Recent Development
11.10 Phesi
11.10.1 Phesi Company Detail
11.10.2 Phesi Business Overview
11.10.3 Phesi AI-based Clinical Trial Solution Introduction
11.10.4 Phesi Revenue in AI-based Clinical Trial Solution Business (2019-2024)
11.10.5 Phesi Recent Development
11.11 Deloitte
11.11.1 Deloitte Company Detail
11.11.2 Deloitte Business Overview
11.11.3 Deloitte AI-based Clinical Trial Solution Introduction
11.11.4 Deloitte Revenue in AI-based Clinical Trial Solution Business (2019-2024)
11.11.5 Deloitte Recent Development
11.12 Innoplexus
11.12.1 Innoplexus Company Detail
11.12.2 Innoplexus Business Overview
11.12.3 Innoplexus AI-based Clinical Trial Solution Introduction
11.12.4 Innoplexus Revenue in AI-based Clinical Trial Solution Business (2019-2024)
11.12.5 Innoplexus Recent Development
11.13 IBM
11.13.1 IBM Company Detail
11.13.2 IBM Business Overview
11.13.3 IBM AI-based Clinical Trial Solution Introduction
11.13.4 IBM Revenue in AI-based Clinical Trial Solution Business (2019-2024)
11.13.5 IBM Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research